Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Shaanxi Panlong Pharmaceutical Group Limited By Share Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
Shaanxi Panlong Pharmaceutical Group Limited By Share has been growing earnings at an average annual rate of 10.9%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 12.6% per year. Shaanxi Panlong Pharmaceutical Group Limited By Share's return on equity is 7.4%, and it has net margins of 12.4%.
Anahtar bilgiler
10.9%
Kazanç büyüme oranı
8.4%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 10.9% |
| Gelir büyüme oranı | 12.6% |
| Özkaynak getirisi | 7.4% |
| Net Marj | 12.4% |
| Sonraki Kazanç Güncellemesi | 28 Oct 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding
Sep 30
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings
May 02Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%
Mar 06Gelir ve Gider Dağılımı
Shaanxi Panlong Pharmaceutical Group Limited By Share nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 936 | 116 | 436 | 24 |
| 31 Mar 24 | 965 | 120 | 439 | 21 |
| 31 Dec 23 | 981 | 110 | 423 | 20 |
| 30 Sep 23 | 997 | 107 | 442 | 25 |
| 30 Jun 23 | 1,043 | 111 | 451 | 25 |
| 31 Mar 23 | 1,001 | 103 | 425 | 19 |
| 01 Jan 23 | 974 | 101 | 424 | 18 |
| 30 Sep 22 | 958 | 98 | 404 | 17 |
| 30 Jun 22 | 917 | 96 | 388 | 15 |
| 31 Mar 22 | 911 | 96 | 399 | 14 |
| 01 Jan 22 | 887 | 93 | 391 | 14 |
| 30 Sep 21 | 842 | 86 | 388 | 14 |
| 30 Jun 21 | 834 | 89 | 377 | 13 |
| 31 Mar 21 | 764 | 87 | 348 | 13 |
| 31 Dec 20 | 670 | 79 | 309 | 13 |
| 30 Sep 20 | 626 | 80 | 296 | 12 |
| 30 Jun 20 | 565 | 66 | 291 | 13 |
| 31 Mar 20 | 571 | 70 | 298 | 13 |
| 31 Dec 19 | 611 | 72 | 326 | 13 |
| 30 Sep 19 | 587 | 76 | 321 | 8 |
| 30 Jun 19 | 564 | 72 | 307 | 10 |
| 31 Mar 19 | 516 | 67 | 295 | 9 |
| 31 Dec 18 | 489 | 65 | 279 | 8 |
| 30 Sep 18 | 442 | 57 | 249 | 9 |
| 30 Jun 18 | 424 | 56 | 234 | 9 |
| 31 Mar 18 | 404 | 46 | 216 | 8 |
| 31 Dec 17 | 377 | 44 | 200 | 7 |
| 30 Sep 17 | 369 | 49 | 182 | 4 |
| 30 Jun 17 | 333 | 44 | 165 | 0 |
| 31 Mar 17 | 305 | 40 | 147 | 0 |
| 31 Dec 16 | 305 | 40 | 143 | 0 |
| 31 Dec 15 | 256 | 43 | 114 | 0 |
| 31 Dec 14 | 246 | 40 | 124 | 0 |
| 31 Dec 13 | 227 | 33 | 118 | 0 |
Kaliteli Kazançlar: 002864 has high quality earnings.
Büyüyen Kar Marjı: 002864's current net profit margins (12.4%) are higher than last year (10.6%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 002864's earnings have grown by 10.9% per year over the past 5 years.
Büyüme Hızlandırma: 002864's earnings growth over the past year (4.8%) is below its 5-year average (10.9% per year).
Kazançlar vs. Sektör: 002864 earnings growth over the past year (4.8%) exceeded the Pharmaceuticals industry -0.6%.
Özkaynak Getirisi
Yüksek ROE: 002864's Return on Equity (7.4%) is considered low.